Literature DB >> 23123794

Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines.

Jung San Chang1, Kuo Chih Wang, Chia Feng Yeh, Den En Shieh, Lien Chai Chiang.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Ginger, Zingiber officinale Roscoe, is a common spice and also a widely used medicinal plant in ancient China. Ginger is an ingredient of Ge-Gen-Tang (Kakkon-to; GGT). GGT has been proved to have antiviral activity against human respiratory syncytial virus (HRSV). However, it is unknown whether ginger is effective against HRSV. AIM OF THE STUDY: To find a readily available agent to manage HRSV infection, the authors tested the hypothesis that ginger can effectively decrease HRSV-induced plaque formation in respiratory mucosal cell lines.
MATERIALS AND METHODS: Effect of hot water extracts of fresh and dried gingers on HRSV was tested by plaque reduction assay in both human upper (HEp-2) and low (A549) respiratory tract cell lines. Ability of ginger to stimulate anti-viral cytokines was evaluated by enzyme-linked immunosorbent assay (ELISA).
RESULTS: Fresh ginger dose-dependently inhibited HRSV-induced plaque formation in both HEp-2 and A549 cell lines (p<0.0001). In contrast, dried ginger didn't show any dose-dependent inhibition. 300 μg/ml fresh ginger could decrease the plaque counts to 19.7% (A549) and 27.0% (HEp-2) of that of the control group. Fresh ginger was more effective when given before viral inoculation (p<0.0001), particularly on A549 cells. 300 μg/ml fresh ginger could decrease the plaque formation to 12.9% when given before viral inoculation. Fresh ginger dose-dependently inhibited viral attachment (p<0.0001) and internalization (p<0.0001). Fresh ginger of high concentration could stimulate mucosal cells to secrete IFN-β that possibly contributed to counteracting viral infection.
CONCLUSIONS: Fresh, but not dried, ginger is effective against HRSV-induced plaque formation on airway epithelium by blocking viral attachment and internalization.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23123794     DOI: 10.1016/j.jep.2012.10.043

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  45 in total

1.  Genetic diversity and structure of Brazilian ginger germplasm (Zingiber officinale) revealed by AFLP markers.

Authors:  Eleonora Zambrano Blanco; Miklos Maximiliano Bajay; Marcos Vinícius Bohrer Monteiro Siqueira; Maria Imaculada Zucchi; José Baldin Pinheiro
Journal:  Genetica       Date:  2016-10-08       Impact factor: 1.082

2.  Medicinal plants used for the management of respiratory diseases in Zimbabwe: Review and perspectives potential management of COVID-19.

Authors:  Elliot Nyagumbo; William Pote; Bridgett Shopo; Trust Nyirenda; Ignatius Chagonda; Ruvimbo J Mapaya; Fabian Maunganidze; William N Mavengere; Cephas Mawere; Ian Mutasa; Emmanuel Kademeteme; Alfred Maroyi; Tafadzwa Taderera; Michael Bhebhe
Journal:  Phys Chem Earth (2002)       Date:  2022-09-21       Impact factor: 3.311

Review 3.  Chewing Gums as a Drug Delivery Approach for Oral Health.

Authors:  Morteza Banakar; Sedigheh Moayedi; Erfan Shamsoddin; Zahra Vahedi; Mohammad Hasan Banakar; Seyyed Mojtaba Mousavi; Dinesh Rokaya; Kamran Bagheri Lankarani
Journal:  Int J Dent       Date:  2022-06-20

4.  Exploring Phytochemicals of Traditional Medicinal Plants Exhibiting Inhibitory Activity Against Main Protease, Spike Glycoprotein, RNA-dependent RNA Polymerase and Non-Structural Proteins of SARS-CoV-2 Through Virtual Screening.

Authors:  Saranya Nallusamy; Jayakanthan Mannu; Caroline Ravikumar; Kandavelmani Angamuthu; Bharathi Nathan; Kumaravadivel Nachimuthu; Gnanam Ramasamy; Raveendran Muthurajan; Mohankumar Subbarayalu; Kumar Neelakandan
Journal:  Front Pharmacol       Date:  2021-07-08       Impact factor: 5.810

5.  Safety and Efficacy of Medicinal Plants Used to Manufacture Herbal Products with Regulatory Approval in Uganda: A Cross-Sectional Study.

Authors:  Bruhan Kaggwa; Henry Kyeyune; Edson Ireeta Munanura; Godwin Anywar; Stephen Lutoti; Jacqueline Aber; Lynn K Bagoloire; Anke Weisheit; Casim Umba Tolo; Pakoyo Fadhiru Kamba; Patrick Engeu Ogwang
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-13       Impact factor: 2.650

Review 6.  Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus.

Authors:  Swapnil Subhash Bawage; Pooja Munnilal Tiwari; Shreekumar Pillai; Vida Dennis; Shree Ram Singh
Journal:  Adv Virol       Date:  2013-12-09

7.  Evaluation of potency of the selected bioactive molecules from Indian medicinal plants with MPro of SARS-CoV-2 through in silico analysis.

Authors:  Pinku Halder; Upamanyu Pal; Pranab Paladhi; Saurav Dutta; Pallab Paul; Samudra Pal; Debasmita Das; Agnish Ganguly; Ishita Dutta; Sayarneel Mandal; Anirban Ray; Sujay Ghosh
Journal:  J Ayurveda Integr Med       Date:  2021-05-21

8.  Identifying potential human and medicinal plant microRNAs against SARS-CoV-2 3'UTR region: A computational genomics assessment.

Authors:  Naman Mangukia; Priyashi Rao; Kamlesh Patel; Himanshu Pandya; Rakesh M Rawal
Journal:  Comput Biol Med       Date:  2021-07-19       Impact factor: 4.589

Review 9.  A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov.

Authors:  Rambod Abiri; Hazandy Abdul-Hamid; Oksana Sytar; Ramin Abiri; Eduardo Bezerra de Almeida; Surender K Sharma; Victor P Bulgakov; Randolph R J Arroo; Sonia Malik
Journal:  Molecules       Date:  2021-06-24       Impact factor: 4.411

10.  Phycobilins as Potent Food Bioactive Broad-Spectrum Inhibitors Against Proteases of SARS-CoV-2 and Other Coronaviruses: A Preliminary Study.

Authors:  Brahmaiah Pendyala; Ankit Patras; Chandravanu Dash
Journal:  Front Microbiol       Date:  2021-06-10       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.